tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Nierengarten, 309 are a BUY (82.18%), 65 are a HOLD (17.29%), 2 are a SELL (0.53%).
Analyst David Nierengarten, currently employed at WEDBUSH, carries an average stock price target met ratio of 46.25% that have a potential upside of 46.18% achieved within 218 days.
David Nierengarten’s has documented 837 price targets and ratings displayed on 65 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on IRON, Disc Medicine at 17-Oct-2025.
Analyst best performing recommendations are on SRRK (SCHOLAR ROCK HOLDING CORP).
The best stock recommendation documented was for SRRK (SCHOLAR ROCK HOLDING CORP) at 6/18/2018. The price target of $25 was fulfilled within 1 day with a profit of $3.57 (16.66%) receiving and performance score of 166.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$70
$34.93 (99.60%)
$40
13 days ago
(14-Oct-2025)
11/19 (57.89%)
$35.74 (104.32%)
108
Buy
$59
$23.93 (68.23%)
$38
28 days ago
(29-Sep-2025)
3/10 (30%)
$28.38 (92.68%)
44
Hold
$20
$-15.07 (-42.97%)
$18
2 months 16 days ago
(11-Aug-2025)
7/12 (58.33%)
$-0.11 (-0.55%)
129
Buy
$80
$44.93 (128.12%)
$42
3 months 4 days ago
(23-Jul-2025)
7/14 (50%)
$53.01 (196.41%)
545
Buy
$90
$54.93 (156.63%)
$54
5 months ago
(27-May-2025)
2/11 (18.18%)
$69.1 (330.62%)
229
Which stock is David Nierengarten is most bullish on?
Which stock is David Nierengarten is most reserved on?
What Year was the first public recommendation made by David Nierengarten?
